![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 47, 36676-36682, November 24, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, March 10, 2000, and in revised form, September 5, 2000
Calreticulin (CRT) is a highly conserved
Ca2+-binding protein that resides in the lumen of the
endoplasmic reticulum (ER). We overexpressed CRT in Xenopus
oocytes to determine how it could modulate inositol 1,4,5-trisphosphate
(InsP3)-induced Ca2+ influx. Under conditions
where it did not affect the spatially complex elevations in free
cytosolic Ca2+ concentration
([Ca2+]i) due to InsP3-induced
Ca2+ release, overexpressed CRT decreased by 46% the
Ca2+-gated Cl Since it was first isolated a quarter of a century ago (1), the
protein calreticulin (CRT)1
has been identified in a great variety of cells, implying an essential
biological activity (2). Although CRT may be critical for cardiac
development (3), to date, the nature of the cellular function of CRT
remains poorly understood. CRT binds to steroid receptors (4, 5) and to
integrins (6, 7) and thus could modulate gene transcription (8, 9) or
cellular adhesion (2, 10-12). To reach these targets, however, CRT
would need to be present both in the nucleus and the cytosol. Although
CRT has been reported in these cellular compartments (see Refs. 2 and
10 but also see Ref. 13), the bulk of the protein clearly resides
elsewhere, i.e. inside the endoplasmic reticulum (ER). Within the ER lumen, CRT may assist in the folding and assembly of
glycoproteins (14-17). ER CRT may also act as a repository of readily
releasable Ca2+, with each mole of CRT binding as many as
20-25 mol of Ca2+. Since Ca2+ release from the
ER is controlled mainly by the second messenger inositol
1,4,5-trisphosphate (InsP3), CRT emerges as a potential regulator of this ubiquitous signal transduction pathway.
The InsP3-induced Ca2+ signal has two main
components, the release of Ca2+ from the intracellular
stores (InsP3-induced Ca2+ release, or IICR)
and the influx of Ca2+ across the plasma membrane
(InsP3-induced Ca2+ influx, or IICI). IICR
starts when InsP3 binds to its intracellular receptor
(InsP3R), a ligand-gated Ca2+ channel that
traverses the lipid membrane surrounding the ER. The resulting
discharge of ER Ca2+ into the cytosol is often spatially
complex, with periodic focal release of Ca2+ actively
spreading to the rest of the cell through mechanisms that remain
incompletely understood (18). IICI commonly follows IICR, thereby
allowing cells to recharge their internal stores. Stimulation of
Ca2+ influx appears closely linked to the depletion of the
intracellular Ca2+ stores, a relationship known as
capacitative Ca2+ entry. We do not yet understand how
Ca2+ store depletion stimulates Ca2+ influx.
Store depletion could communicate with the plasma membrane through a
diffusible messenger (19, 20), through secretion-like vesicular docking
(21, 22), or through protein-protein interactions that may involve the
InsP3R itself (23-25).
Even though Ca2+ storage was the first function ascribed to
CRT (1), we do not yet know what role, if any, CRT plays in the regulation of the InsP3-induced Ca2+ signal.
Whereas gene knock-out experiments indicate that CRT is not essential
for IICR (11), overexpression of CRT has been associated with a
decrease in the magnitude of IICI in mammalian cell lines (26-28).
These results have prompted the hypothesis that CRT reduces
capacitative Ca2+ entry by buffering the free
Ca2+ concentration within the ER lumen
([Ca2+]ER) above the levels required to
trigger capacitative Ca2+ influx. In this work, our
objective was to put this hypothesis to a rigorous test by directly
measuring [Ca2+]ER in a widely used model
cell, the Xenopus oocyte. Our data indicate that CRT
requires its high capacity Ca2+-binding domain both to
attenuate the InsP3-induced decrease in [Ca2+]ER and to reduce the elevations of
[Ca2+]i due to IICI. The ability of CRT to buffer
[Ca2+]ER may thus be functionally relevant to
the InsP3-induced Ca2+ signal.
CRT and CRT Deletion Mutant Expression Vectors--
We inserted
the CRT cDNA cloned from the HL60 human leukemia cell line (29)
between the PstI and SalI sites of the pMT3 plasmid vector (30). We used the polymerase chain reaction (PCR) to
build CRT mutants lacking functional domains. To remove the C-domain
(CRT- cDNA-directed Protein Expression and Western
Blotting--
We prepared stage V-VI oocytes from albino
Xenopus laevis and injected the DNA constructs into the
nucleus as described previously (31, 32). Oocyte microsome
purification, protein solubilization, SDS-polyacrylamide gel
electrophoresis, and transfer to nitrocellulose were as outlined in the
past (33). For immunoblotting, we used a polyclonal antibody raised
against the full-length recombinant HL60 CRT (29). We performed all our
functional studies 48-72 h after plasmid injection, when CRT
expression level was found to be maximal in preliminary experiments.
Electrophysiology--
We assayed [Ca2+]i
by measuring Ca2+-activated Cl
To ensure that the individual cells studied electrophysiologically
expressed the protein of interest, plasmid cDNA coding for CRT or
CRT mutants was co-injected with pMT3-sg25 (20:1 concentration ratio),
a vector coding for an enhanced green fluorescent protein (GFP). We
performed electrophysiology experiments on those live cells that showed
the highest GFP fluorescence.
Monitoring [Ca2+]ER with Fluorescence
Resonance Energy Transfer (FRET)--
We excised the "yellow
chameleon-3er or -4er" (3er or 4er) cDNAs (gifts from Dr. Roger
Y. Tsien, Howard Hughes Medical Institute, University of California,
San Diego, CA) from the pcDNA vector and inserted them between the
NotI and EcoRI sites of pMT3. The 3er/4er
Ca2+ indicators contain two mutated GFP yielding cyan (CFP)
or yellow (YFP) fluorescence (44). The amino acids linking YFP to CFP include the sequences for CaM and for the M13 CaM-binding peptide. Upon
Ca2+ binding, CaM enfolds M13 thereby creating FRET between
YFP and CFP. To enable measurements of the relatively high
[Ca2+]ER, CaM sequences of 3er and 4er were
modified to lower their affinity for Ca2+ (44). 3er and 4er
also include sequences from CRT that allow their retrieval into the ER
lumen. To measure FRET, we illuminated oocytes expressing 3er/4er
( Immunolocalization--
Oocyte cryosections (5 µm thick) were
incubated for 30 min first with 1/200-1/500 dilutions of the anti-CRT
antibody and then with a fluorescein isothiocyanate-conjugated
anti-rabbit secondary antibody, and examined with a fluorescence
microscope as described before (32). For ultrastructural studies,
cryosections (10 µm thick) were fixed, incubated for 1 h in
anti-CRT antibody and then overnight in anti-rabbit antibody conjugated
to 5 nm gold particles (Janssen Life Sciences Products, Piscataway,
NJ), and prepared for examination under in a Hitachi 7000 electron
microscope (Hitachi Ltd., Tokyo) as described previously (32).
45Ca2+ Uptake--
Oocytes injected
either with pMT3 alone or with pMT3-CRT were incubated in
45Ca2+-containing solution (8 µCi/ml).
45Ca2+-related counts increased gradually and
reached a plateau at 36-48 h, indicating equilibration across the
Ca2+-binding compartments of the oocyte. After a 72-h
incubation period, chosen to ensure isotopic equilibrium, intact
oocytes were washed 5 times in cold solution and individually
transferred to scintillation vials for counting. Alternatively, the
washed oocytes were combined and homogenized, and their microsomes were
purified and recovered on filter paper prior to counting, as per our
previously published methodology (33).
Calcium Imaging and Confocal Microscopy--
Oocytes were
injected with either fluo 3 alone (250 µM),
Ca2+ orange alone (250 µM), or a mixture of
fluo 3 (100 µM) and fura red (300 µM)
(Molecular Probes). They were then stimulated with a 30-nl droplet of
Ins(2,4,5)P3 (10 µM) and the resulting
fluorescence visualized on a confocal microscope as described
previously (46). Ca2+ wave amplitude, velocity, frequency,
as well as rates of rise/decrease in [Ca2+]i at
the wave fronts were determined as detailed before (32). To compare
[Ca2+]i between different cells using visible
excitation wavelengths, we ratioed the simultaneously measured
fluorescence signal from fluo 3 and fura red (45). The detailed
validation of this technique in the oocyte has been previously
published (32). Image analysis was performed using the NIH Image
version 1.61 software.
Overexpression of CRT in Xenopus Oocytes--
On a Western blot of
microsomal proteins from which we have previously purified CRT, the ER
lumenal protein calsequestrin and the InsP3R (33, 47), an
anti-CRT antibody (29), labeled an ~60-kDa protein (Fig.
1, 1st lane). After
injection with pMT3-CRT, the density of this band increased
significantly, indicating overexpression of CRT (Fig. 1, 2nd
lane). Immunostaining revealed reticular fluorescence that
increased from the vegetal to the animal pole of the cell in a pattern
similar to that of control cells, but much brighter (Fig.
2). We observed a similar fluorescence
pattern with overexpressed InsP3R (32). Under electron
microscopy using a gold-labeled secondary antibody targeted at an
anti-CRT primary antibody, the gold particles were found in association
with membranous cisternae most likely representing elements of the ER
(Fig. 3). There was no label associated
with mitochondria or with other organelles. Given CRT's ER retrieval
sequences and lack of hydrophobic regions that can stretch across lipid
bilayers, our data suggest that CRT is overexpressed within the ER
lumen.
CRT Decreases the [Ca2+]i Elevations Due to
Ca2+ Influx--
To investigate the effect of CRT
overexpression on Ca2+ influx, we microinjected either pMT3
or pMT3-CRT in oocytes. We then stimulated the cells with a saturating
concentration of InsP3 (10 nl of
10 CRT Attenuates the InsP3-induced Decline in
[Ca2+]ER--
In the context of capacitative
Ca2+ entry, CRT could reduce IICI by buffering
[Ca2+]ER to levels above those required to
stimulate Ca2+ influx. Because neither the precise value of
[Ca2+]ER nor the degree to which CRT
contributes to the overall Ca2+-binding properties of the
ER lumenal milieu is presently known, we could not confidently predict
if/how altered CRT levels affect [Ca2+]ER. To
test this hypothesis, we therefore monitored
[Ca2+]ER directly with an ER-targeted FRET
indicator, chameleon 3er (3er) (44). At base line, the 535/485
fluorescence emission ratios in cells co-expressing 3er and CRT were
similar to the ratios found in cells expressing 3er alone (1.08 ± 0.07 versus 1.09 ± 0.07, n = 16 matched cell pairs). Because the 3er indicator saturates at
[Ca2+] in excess of 100 µM (44), we
repeated the experiments, this time expressing a lower affinity
indicator, 4er, that could report [Ca2+]ER
between 10
When microinjected with InsP3
(10
The ability of CRT to maintain [Ca2+]ER near
resting levels uncouples Ca2+ store depletion from
intracellular InsP3 levels in a novel way; unlike the
Ca2+ ATPase inhibitor thapsigargin, which deplete the
stores at basal InsP3 levels, overexpressed CRT prevented
store depletion despite high InsP3 levels. Recent evidence
suggests that the role played by the InsP3R in
Ca2+ influx extends beyond simply lowering
[Ca2+]ER (25). In this context, our direct
measurements of [Ca2+]ER serve as a reminder
that store depletion is required to stimulate Ca2+ influx
and that elevated InsP3, by itself, is not sufficient.
Effect of CRT on IICR--
The simplest mechanism by which CRT
could prevent the InsP3-induced decrease in
[Ca2+]ER would be to inhibit IICR. However,
our data suggested that this was not the case with saturating
concentrations of InsP3; in the cells where CRT had
decreased the Ca2+ influx-related Cl Effect of CRT on Ca2+ Uptake and/or Ca2+
Extrusion--
CRT could blunt the InsP3-induced decrease
in [Ca2+]ER if it accelerated the reuptake of
cytosolic Ca2+ into the ER lumen. To investigate this
alternative hypothesis, we first estimated the rate at which
[Ca2+]i returns to base line following the
passage of a Ca2+ wave front using an analysis similar to
that described in the preceding paragraph. We found that the rate of
[Ca2+]i decline was not accelerated in cells
expressing CRT (Fig. 6B). Next, we scanned the site of an
intracellular injection of CaCl2 (1 nl, 50 mM)
with a single laser line (scanning rate = 500 Hz) in oocytes
loaded with fluo 3. Fluorescence due to this exogenous addition of
Ca2+ returned to base line at a slower rate in oocytes
expressing CRT (Fig. 6B). To assay more specifically
Ca2+ uptake into the intracellular stores, we compared the
ATP-dependent 45Ca2+ uptake into
microsomes isolated either from cells overexpressing CRT or from
control cells. At 3 min, the time that the microsomes reach 50% of
their total ATP-dependent 45Ca2+
uptake (33), we found a trend toward lower
45Ca2+ accumulation in microsomes from cells
overexpressing CRT (Fig. 6B, p < 0.06).
Together with the Ca2+ injections experiments, these last
results suggest that CRT overexpression slows the rate of
Ca2+ uptake into filled stores. In contrast, our data with
the Ca2+ waves suggest that CRT does not measurably affect
the rate of Ca2+ reuptake into InsP3-depleted
stores. Our results are thus compatible with a previous report of CRT
inhibiting the ER Ca2+ ATPase (55) but further suggest that
this inhibition can be overcome when [Ca2+]ER
decreases. Overall, these data do not support our alternative hypothesis that CRT reduces the InsP3-induced decline in
[Ca2+]ER by accelerating Ca2+
reuptake/extrusion.
CRT Increases Cellular and Microsomal Ca2+-binding
Capacity--
If CRT increases neither the magnitude of IICR nor the
rate at which Ca2+ is retrieved back into the ER, then CRT
could attenuate the InsP3-induced decrease in
[Ca2+]ER simply by increasing the
Ca2+-buffering capacity of the store; with more
Ca2+ to start with, more Ca2+ should remain in
the stores following InsP3 stimulation. To measure the
impact of CRT overexpression on cellular Ca2+ content, we
incubated oocytes with 45Ca2+ for 72 h, a
time sufficient for the isotope to equilibrate across the
Ca2+-binding compartments of the cell;
45Ca2+-related counts were 52 ± 14%
higher in cells expressing CRT than they were in control cells (84 cell
pairs from five different frogs, p < 0.02). Microsomes
purified from groups of 10 CRT-expressing oocytes had
45Ca2+-related counts that were 59.3 ± 10% greater than controls (n = 4, p < 0.007). These data indicate that CRT overexpression increases whole
cell and microsomal Ca2+ content and thus support the
notion that CRT acts as a high capacity Ca2+ buffer
in vivo. Because 80% of the ionomycin-releasable
Ca2+ in these microsomes is InsP3-sensitive
(33), these data further suggest that CRT levels can influence the
capacity of the InsP3-sensitive Ca2+ pools of
the oocyte.
High Capacity Ca2+-binding Domain of CRT Is Required to
Prevent InsP3-induced Store Depletion and to Reduce
IICI--
To probe the relationship between Ca2+-buffering
properties of CRT and its ability to curb the InsP3-induced
decrease in [Ca2+]ER, we deleted the
C-terminal domain, or C-domain (CRT-
At isotopic equilibrium, whole oocytes or microsomes extracted from
oocytes expressing CRT-
The InsP3-induced decline in the 535/485 emission ratio of
3er was smaller in cells co-expressing CRT- CRT Does Not Prevent Thapsigargin-induced Store Depletion from
Fully Activating Ca2+ Influx--
If CRT acts primarily as
a Ca2+ buffer to reduce Ca2+ influx, then a
prolonged depletion of the Ca2+ stores should eventually
lead to a full activation of Ca2+ influx. To test this
hypothesis, we incubated oocytes with the Ca2+-ATPase
inhibitor thapsigargin for 3 h (42), and we directly measured the
resulting whole cell Ca2+ influx current according to the
protocol of Yao and Tsien (43). As the tracings in Fig.
8A exemplify, the magnitude of
the thapsigargin-induced Ca2+ influx current in cells
overexpressing CRT was similar to that of controls (aggregate data for
7 cell pairs shown in Fig. 8B). Experiments with
3er-expressing oocytes confirmed that thapsigargin exposure decreases
[Ca2+]ER to a similar extent in control and
in CRT-expressing cells (Fig. 8C). By demonstrating that
store depletion can still fully stimulate Ca2+ influx in
cells overexpressing CRT, these data further support the hypothesis
that CRT controls InsP3-induced Ca2+ influx by
buffering [Ca2+]ER.
In summary, our results establish that an increase in calreticulin
levels can reduce the InsP3-induced decline in
[Ca2+]ER, thereby confirming the proposal
originally put forth by Pozzan and co-workers (26, 28). The
experimental results also link the high Ca2+-buffering
capacity of CRT to its ability both to prevent Ca2+ store
depletion and to reduce Ca2+ influx. Taken together, the
results directly support the notion that changing levels of CRT can
alter [Ca2+]ER within ranges that are
relevant to the cellular mechanisms that control
InsP3-induced Ca2+ influx.
*
This work was supported by grants from the Department of
Veterans Affairs (to S. D. and R. A. C.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
**
Established Investigator at the American Heart Association. To whom
correspondence should be addressed: Depts. of Medicine and Physiology,
University of Maryland, 3B-185 Veterans Affairs Medical Center, 10 N. Greene St., Baltimore MD 21201. Tel.: 410-605-7000 (ext. 6449); Fax:
410-605-7957; E-mail: sdelisle@umaryland.edu.
Published, JBC Papers in Press, September 5, 2000, DOI 10.1074/jbc.M002041200
The abbreviations used are:
CRT, calreticulin;
CaM, calmodulin;
ER, endoplasmic reticulum;
[Ca2+], Ca2+ concentration;
[Ca2+]i, free cytosolic
[Ca2+];
[Ca2+]ER, free ER
lumenal [Ca2+];
FRET, fluorescence resonance energy
transfer;
GFP, YFP, and CFP, green, yellow, and cyan fluorescent
protein, respectively;
IICI, InsP3-induced Ca2+
influx;
IICR, InsP3-induced Ca2+ release;
InsP3, D-myo-inositol
1,4,5-trisphosphate;
InsP3R, inositol 1,4,5-trisphosphate
receptor;
PCR, polymerase chain reaction.
Calreticulin Modulates Capacitative Ca2+ Influx by
Controlling the Extent of Inositol 1,4,5-Trisphosphate-induced
Ca2+ Store Depletion*
,
,
, and
**
Veterans Affairs Medical Center and
Departments of Medicine and Physiology, University of Maryland School
of Medicine, Baltimore, Maryland 21201, the § Department
of Anatomy, ¶ University of Iowa College of Medicine,
Iowa City, Iowa 52242, and the
Department of Medicine, South
Texas Veterans Health Care System and University of Texas Health
Science Center, San Antonio, Texas 78230
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
current due to Ca2+
influx. Deletion mutants revealed that CRT requires its high capacity
Ca2+-binding domain to reduce the elevations of
[Ca2+]i due to Ca2+ influx. This
functional domain was also required for CRT to attenuate the
InsP3-induced decline in the free Ca2+
concentration within the ER lumen ([Ca2+]ER),
as monitored with a "chameleon" indicator. Our data suggest that by
buffering [Ca2+]ER near resting levels, CRT
may prevent InsP3 from depleting the intracellular stores
sufficiently to activate Ca2+ influx.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
C), we amplified the N and P domains of CRT (amino acids
2-315) and added a KDEL ER retrieval sequence at the C terminus (primers 1 and 2). The PCR fragment was digested with MluI
and EcoRI and inserted between those sites in a modified
pMT3. For the construct lacking the P-domain (CRT-
P), we amplified
the N-domain (amino acids 2-197, primers 1 and 3) and the C-domain (amino acids 316-401, primers 4 and 5) separately. The PCR fragments were then respectively digested with MluI/SpeI
and with SpeI/EcoRI and ligated between the
MluI and the EcoRI sites of pMT3. Primers sequence were as follows, from 5' to 3': primer 1, GTCACGCGTCTGCTATCCGTGCCGCTG; primer 2, CGGAATTCTCAGAGTTCATCCTTGCCCAGCACGCCAAAGTTATC; primer 3, CGTACTAGTTTCCAAGGAGCCGGAC; primer 4, GTCACTAGTCTGGATCTCTGGCAAGTCAAGTCTGG; primer 5, CGGAATTCTCATTCGAGTCTCACAGAGAC.
currents with
the two-electrode voltage clamp technique (31). This assay has been
validated using Ca2+-sensitive electrodes (34-36) and
fluorescent Ca2+ indicators (31, 37-41). We performed
intracellular injections and calibrated the injection pipettes as we
had done in the past (31). Bath solution contained (in mM)
the following: 116 NaCl, 2.0 KCl, 1.8 CaCl2, 1 MgCl2, 5 HEPES, pH 7.4. In the experiments where
Ca2+ stores were to be irreversibly depleted, oocytes were
incubated with 2 µM thapsigargin (Calbiochem) for 3 h (42, 43). Cells were then microinjected with 4 nmol of either EGTA
(Sigma) or 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic
acid (Molecular Probes, Eugene, OR) to prevent
[Ca2+]i elevations from activating the
Ca2+-activated Cl
currents. Cells were then
put into a bath solution (in mM, either 70 MgCl2 or 70 CaCl2, 10 HEPES, pH 7.2), and the
inward Ca2+ currents resulting from the influx of
extracellular Ca2+ were directly measured with the
two-electrode voltage clamp technique (43).
= 440 ± 15 nm, DeltaRam monochromator, Photon
Technology International, Monmouth Junction, NJ, 455DCLP dichroic
mirror) and recorded the emission intensity at two wavelengths, 485 and
535 nm, using separate photomultiplier tubes (520DCLP dichroic mirror,
D485/40M and D5356/30M emission filters, Chroma Technology,
Brattleboro, VT). If we could not calibrate 3er in vivo, we
could nevertheless use the 535/485 fluorescence ratio to compare
[Ca2+]ER among cells submitted to identical
illumination. In these experiments, the gains of the photomultiplier
tubes were carefully matched, and neutral black levels were determined
experimentally (45).
![]()
RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

View larger version (64K):
[in a new window]
Fig. 1.
Overexpression of CRT in Xenopus
oocyte. A, each lane represents an identical
amount of solubilized microsomal protein submitted to
SDS-polyacrylamide gel electrophoresis, transferred to nitrocellulose,
and blotted with a polyclonal antibody against HL60-CRT. When compared
with controls (1st lane), CRT (bands facing the
closed arrow) was increased in cells microinjected with
pMT3-CRT (2nd lane). Note the appearance of new
bands (open arrow) in cells microinjected with pMT3-CRT-
P
(doublet in 3rd lane) or pMT3-CRT-
C
(4th lane).

View larger version (142K):
[in a new window]
Fig. 2.
Localization of CRT by
immunofluorescence. Anti-CRT staining shows a marked increase in
fluorescence signal in CRT-expressing oocytes (lower panels)
compared with controls (upper panels). The reticular
pattern, the subcortical columns (arrowheads), and the
decreasing fluorescence from the animal pole (A and
D) to the equatorial region (B and E)
and to the vegetal pole (C and F) is typical of
the ER distribution in oocytes. Oocytes exposed only to the secondary
antibody were negative.

View larger version (116K):
[in a new window]
Fig. 3.
Localization of CRT by immunogold
staining. Electron microscopy at the animal pole of an oocyte
overexpressing CRT is indicated. Gold particles targeted against an
anti-CRT antibody are associated with cisternae of endoplasmic
reticulum (arrowheads).
3 M solution or a 10 µM average concentration) and assayed
[Ca2+]i by measuring Ca2+-gated
Cl
current with the two-electrode voltage clamp
technique. The Ca2+-gated Cl
current reflects
[Ca2+]i just beneath the plasma membrane (48,
49), where it is most likely to be affected by Ca2+ influx.
The assay integrates the submembranous [Ca2+]i
changes across the entire surface of the plasma membrane, thereby
maximizing our ability to detect changes in the magnitude of
Ca2+ influx. In control cells, microinjection of
InsP3 (10
3 M in the
pipette) causes a biphasic response; there is a short initial increase
in [Ca2+]i followed by a slow increase (Fig.
4A). The fast initial component of the response, which is not affected by the removal of
extracellular Ca2+, is due to the release of
Ca2+ from the intracellular stores (50, 51). In contrast,
the slow component of the response can be inhibited by decreasing the
extracellular Ca2+ concentration or by adding inorganic
Ca2+ channel blockers (Mn2+, Ni2+,
and La3+) to the bath and thus depends on Ca2+
influx (50-52). Although the magnitude of the Cl
currents due to IICR was similar to that of control cells (272 ± 28 nA in CRT versus 247 ± 23 nA in controls,
n = 31 pairs of cells), the Ca2+
influx-dependent Cl
current was reduced
almost in half in cells overexpressing CRT (77 ± 15 nA
versus 143 ± 19 nA in controls, n = 31 matched pairs of cells, one of which is shown in Fig. 4,
p < 0.001). These results, which are consistent
with those obtained in mammalian cell lines (26, 27), indicate that CRT
reduces the rise in [Ca2+]i due to
Ca2+ influx. Direct measurements of whole cell current due
to Ca2+ or Ba2+ entry have indicated that the
Ca2+-gated Cl
current assay has a high
sensitivity for measuring the magnitude of Ca2+ influx (22,
43). Thus, our results suggest that CRT overexpression reduces the rate
at which extracellular Ca2+ enters the cell.

View larger version (13K):
[in a new window]
Fig. 4.
Effect of CRT overexpression on the
[Ca2+]i elevations due to Ca2+
influx. Successive experiments performed in a control cell
(A) and a CRT-overexpressing cell (B) are shown.
Each tracing represent the Cl
current response to an
intracellular injection of Ins(1,4,5)P3 (arrow)
as a function of time. Downward deflection (inward current) represents
an increase in [Ca2+]i. Note that the slow
component of the biphasic response in the control cell (A)
can be inhibited by lowering the extracellular [Ca2+]
from 6 to 0.1 mM (bar) and is therefore due to
Ca2+ influx. The Cl
current due to
Ca2+ influx is markedly diminished in the cell
overexpressing CRT (B).
4 and 10
2
M. The 535/485 ratios in cells co-expressing 4er and CRT
were also similar to the ratios found in control cells (0.79 ± 0.04 versus 0.81 ± 0.05, n = 6 matched
cell pairs). These data indicate that overexpressed CRT does not
measurably change the resting [Ca2+]ER.
4 M in the pipette), the
control oocyte showed a reversible decrease in the 535/485 fluorescence emission ratio of 3er, indicating a decrease in
[Ca2+]ER (see Fig.
5A). As shown in Fig.
5B, cells co-expressing CRT reached a smaller
InsP3-induced decline in the 535/485 emission ratio of 3er
than did control cells (2.8 ± 0.8% versus 8.3 ± 0.6%, n = 16 matched cell pairs, p < 10
5), suggesting that CRT overexpression
attenuates the InsP3-induced decline in
[Ca2+]ER.

View larger version (23K):
[in a new window]
Fig. 5.
Effect of CRT-overexpression on
[Ca2+]ER. A, in a cell
expressing the 3er FRET indicator and injected with InsP3
(arrow), the emission intensity increases at 485 nm
(upper tracing, left axis) and decreases at 535 nm
(middle tracing, left axis). Thus, the 535/485 fluorescence
intensity ratio (lower tracing, right axis) decreases
reversibly as function of time, indicating a decrease in
[Ca2+]ER. B, peak decline in the
535/485 ratio of 3er due to an injection of InsP3 is more
pronounced in cells expressing 3er alone (closed circles on
the left) than in cells co-expressing 3er and CRT
(open circles on the right). Base-line 535/485
ratio was normalized to 1.
current,
there was no change in the initial Cl
currents due to
IICR. Yet, in oocytes, CRT was previously reported to inhibit the
Ca2+ waves triggered by sub-maximal concentrations of
Ins(1,4,5)P3 (53). To test the effect of CRT on the spatial
aspects of IICR under experimental conditions where it could reduce
Ca2+ influx, we microinjected sub-maximal InsP3
concentrations into oocytes loaded with fluorescent Ca2+
indicators and visualized the resulting Ca2+ waves with a
confocal microscope (46, 54). As shown in Fig. 6A, overexpression of CRT did
not affect the amplitude, the velocity, or the frequency of the
repetitive Ca2+ waves. To determine whether an increase in
CRT levels changes the rate at which Ca2+ is released from
intracellular stores, we examined the fluorescence intensity along a
narrow linear path running perpendicular to the wave front; by
multiplying the average slope of the increasing fluorescence values at
the wave front (
F/
distance) by the instantaneous speed of the wave (
distance/
time), we obtained the rate at which [Ca2+] rises at the wave front (
F/
time) (32). The rate of rise in fluorescence intensity over base line
at the wave front was 38 ± 4% s
1 for
control cells and 36 ± 2% s
1 for
CRT-expressing cells (19 wave pairs were randomly chosen from 8 CRT/control cell pairs) suggesting a similar rate of Ca2+
release at the wave front (Fig. 6A). Although our results
that CRT expression did not change the amplitude of the
Ca2+ waves agree with those of Camacho and
Lechleiter (53), we did not find that CRT decreases Ca2+
waves frequency. Many reasons could explain this difference. 1) We
studied our cells 2-3 days after DNA injection, whereas Camacho's
group studied theirs after 5-7 days. Although we studied our cells at
a time when CRT was already expressed maximally and could reduce
Ca2+ influx, we may have missed a
time-dependent effect of CRT on the Ca2+ waves.
2) We studied only those cells that had proven exogenous protein
expression and that had preserved plasma membrane electrical resistance. Camacho and Lechleiter (53) did not screen
individual cells for protein overexpression or for plasma membrane
electrical integrity. Thus, the reported decrease in the frequency of
Ca2+ waves could not be unequivocally ascribed to an
increase in CRT levels and may have been restricted to cells that were
electrically leaky. 3) Most of the experimental data reported by
Camacho and Lechleiter (53) were obtained in cells co-expressing
the Ca2+-ATPase SERCA2b. In a later publication, the same
group (55) reported that CRT-
C, which had inhibited the
Ca2+ waves in cells co-expressing SERCA2b, had no effect on
the Ca2+ waves in cells co-expressing SERCAs lacking an
ER-lumenal glycosylation site. Thus, their results may mainly reflect
an interplay between CRT and SERCA2b (55). Our results suggest that
under conditions where an increased amount of CRT within the ER can
reduce the InsP3-induced decline in
[Ca2+]ER, CRT does not materially affect the
mechanisms that initiate and propagate Ca2+ waves. Thus,
CRT does not appear to diminish the InsP3-induced decline
in [Ca2+]ER by inhibiting IICR.

View larger version (14K):
[in a new window]
Fig. 6.
Effect of CRT overexpression on
InsP3-induced Ca2+ waves and
on Ca2+ uptake. Each bar represent the mean
value of a measured parameter in CRT-overexpressing cells as a percent
of control values. A, effect of CRT overexpression on
InsP3-induced Ca2+ waves. The five parameters
measured were (bars from left to
right) as follows: 1) basal [Ca2+] before the
passage of a Ca2+ wave; 2) peak [Ca2+] at the
wave front; 3) instantaneous wave velocity; 4) frequency of the
repetitive waves; 5) rate of Ca2+ release at the wave
front. B, effect of CRT overexpression on Ca2+
reuptake/extrusion. The three parameters measured were the rate at
which peak [Ca2+]i decreases following either the
passage of a Ca2+ wave (1st bar) or
an intracellular injection of CaCl2 (2nd
bar) and the ATP-dependent
45Ca2+ accumulation into purified microsomes
(3rd bar). The number of Ca2+ wave
pairs compared across 8-11 matched cell pairs is indicated above the 5 bars of A and the 1st bar of B. Number
of experimental pairs is indicated above the 4th bar of
A and the 2nd and 3rd bars of B. Asterisk indicates statistically significant difference compared
with controls (p < 0.05). Except for slowing the
return to basal [Ca2+]i following a
Ca2+ injection, CRT overexpression affected none of the
measured parameters.
C), which is responsible for the
high Ca2+-binding capacity of CRT (13). To serve as a
control, and to investigate the alternative possibility that CRT could
regulate the InsP3-induced Ca2+ signal by
sensing a decrease in [Ca2+]ER (53), we also
made a mutant lacking the P-domain (CRT-
P), which contains the only
high affinity Ca2+-binding site of CRT (13). Successful
expression of both deletion mutants was confirmed by Western blotting
(Fig. 1, 3rd and 4th lanes).
C had 45Ca2+-related
counts that were no different from controls (respectively 103 ± 8% (25 cell pairs) and 91 ± 6% (n = 3) of
controls (100%)). In contrast, oocytes or microsomes from oocytes
expressing CRT-
P had greater 45Ca2+ counts
than did controls (respectively, 148 ± 13% (25 cell pairs, p < 0.004) and 174 ± 14%
(n = 3, p < 0.01) of controls
(100%)) (Fig. 7A). Thus, CRT-
P
increased cellular and microsomal
Ca2+-binding capacity to an extent similar to that observed
with wild-type CRT. These results confirm that it is the C-domain that
confers on CRT the ability to bind large quantities of
Ca2+. Because this additional Ca2+ binds to the
C-domain with low affinity (Kd ~2 mM), it should therefore be readily available for release into the cytosol
upon opening of the InsP3R. Yet, CRT overexpression did not
affect the elevations in [Ca2+]i due to IICR.
Thus, additional releasable Ca2+ appears to have little
impact on the magnitude of IICR in cells that already own substantial
intracellular Ca2+ reserves.

View larger version (23K):
[in a new window]
Fig. 7.
The C-domain mediates the functional effects
of CRT. The consequence of overexpressing either full-length CRT,
CRT-
P, or CRT-
C on 45Ca2+ uptake into
whole cells (filled bars) or microsomes (open
bars), expressed as a percent of control values (A);
the InsP3-induced decrease in
[Ca2+]ER, expressed as a percent decrease
from the base-line 535/485 emission ratio of 3er (B); and
the magnitude of the Ca2+-gated Cl
current
due to IICR (closed bars) or IICI (hatched bars),
expressed as a percent of control values (C).
Asterisk indicates statistically significant difference
(p < 0.01). Note that CRT-
P, but not CRT-
C,
matches the ability of CRT to increase the cellular and microsomal
Ca2+-binding capacity (A), prevent the
InsP3-induced decline in [Ca2+]ER
(B), and the [Ca2+]i elevations due to
IICI (C).
P than it was either in
cells co-expressing CRT-
C (2.6 ± 0.9% versus
8.3 ± 1.4% decline, respectively, n = 11 pairs,
p < 0.002) or in control cells (7.9 ± 0.8%, n = 11) (Fig. 7B). As shown in Fig.
7C, CRT-
P reduced the Cl
currents due to
Ca2+ influx, whereas CRT-
C did not; neither protein
changed the magnitude of the initial Cl
current due to
intracellular Ca2+ release. Taken together, these data
indicate that CRT relies on the C-domain both to blunt the
InsP3-induced decline in [Ca2+]ER
and to reduce the [Ca2+]i elevations due to
IICI.

View larger version (12K):
[in a new window]
Fig. 8.
Thapsigargin decreases
[Ca2+]ER and fully activates Ca2+
influx in CRT-expressing cells. A and B,
following thapsigargin exposure, an inward current (downward
deflection) is induced by switching the divalent cation in the bath
solution from Mg2+ (70 mM) to Ca2+
(70 mM) (bar in A). Note that this
current is of similar magnitude in control (left tracing in
A, closed bar in B) and in
CRT-expressing oocytes (right tracing in A,
open bar in B); C, thapsigargin
induced a similar decline in the 535/485 fluorescence ratio of 3er in
control (closed bar, n = 10) and
CRT-expressing oocytes (open bar, n = 12).
![]()
FOOTNOTES
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
1.
Ostwald, T. J.,
and MacLennan, D. H.
(1974)
J. Biol. Chem.
249,
974-979
2.
Michalak, M.,
Milner, R. E.,
Burns, K.,
and Opas, M.
(1992)
Biochem. J.
285,
681-692
3.
Mesaeli, N.,
Nakamura, K.,
Zvaritch, E.,
Dickie, P.,
Dziak, E.,
Krause, K. H.,
Opas, M.,
MacLennan, D. H.,
and Michalak, M.
(1999)
J. Cell Biol.
144,
857-868
4.
Dedhar, S.,
Rennie, P. S.,
Shago, M.,
Hagestelijn, C.-Y. L.,
Yang, H.,
Filmus, J.,
Hawley, R. G.,
Bruchovsky, N.,
Cheng, H.,
Matusik, R. J.,
and Giguère, V.
(1994)
Nature
367,
480-483
5.
Burns, K.,
Duggan, B.,
Atkinson, E. A.,
Famulski, K. S.,
Nemer, M.,
Bleacklsy, R. C.,
and Michalak, M.
(1994)
Nature
367,
476-480
6.
Leung-Hagesteijn, K.,
Milankov, C.-Y.,
Michalak, M.,
and Wilkins, J.
(1994)
J. Cell Sci.
107,
589-600
7.
Opas, M.,
Szweczenko-Pawlikowska, M.,
Jass, G. H.,
Mesaeli, N.,
and Michalak, M.
(1996)
J. Cell Biol.
135,
1-11
8.
Michalak, M.,
Burns, K.,
Andrin, C.,
Mesaeli, N.,
Jass, G. H.,
Busaan, J. L.,
and Opas, M.
(1996)
J. Biol. Chem.
271,
29436-29445
9.
Perrone, L.,
Tell, G.,
and Di Lauro, R.
(1999)
J. Biol. Chem.
274,
4640-4645
10.
Dedhar, S.
(1994)
Trends Biochem. Sci.
19,
269-271
11.
Coppolino, M. G.,
Woodside, M. J.,
Demaurex, N.,
Grinstein, S.,
St-Arnaud, R.,
and Dedhar, S.
(1997)
Nature
386,
843-847
12.
Fadel, M. P.,
Dziak, E.,
Lo, C. M.,
Ferrier, J.,
Mesaeli, N.,
Michalak, M.,
and Opas, M.
(1999)
J. Biol. Chem.
274,
15085-15094
13.
Krause, K.-H.,
and Michalak, M.
(1997)
Cell
88,
439-443
14.
Zhang, J. X.,
Braakman, I.,
Matlack, K. E.,
and Helenius, A.
(1997)
Mol. Biol. Cell
8,
1943-1954
15.
Fujino, I.,
Yamada, N.,
Miyawaki, A.,
Hasegawa, M.,
Furuichi, T.,
and Mikoshiba, K.
(1995)
Cell Tissue Res.
280,
201-210
16.
Peterson, J.,
Ora, A.,
Van, P. N.,
and Helenius, A.
(1995)
Mol. Biol. Cell
6,
1173-1184
17.
Nauseef, W. M.,
McCormick, S. J.,
and Goedken, M.
(1998)
J. Biol. Chem.
273,
7107-7111
18.
Thomas, A. P.,
Bird, G. S.,
Hajnoczky, G.,
Robb-Gaspers, L. D.,
and Putney, J. W.
(1996)
FASEB J.
10,
1505-1517
19.
Randriamampita, C.,
and Tsien, R. Y.
(1993)
Nature
364,
809-814
20.
Parekh, A. B.,
Terlau, H.,
and Stühmer, W.
(1993)
Nature
384,
814-818
21.
Patterson, R. L.,
van Rossum, D. B.,
and Gill, D. L.
(1999)
Cell
98,
487-499
22.
Yao, Y.,
Ferrer-Montiel, A. V.,
Montal, M.,
and Tsien, R. Y.
(1999)
Cell
98,
475-485
23.
Putney, J. W.
(1997)
Cell Calcium
21,
257-261
24.
Kiselyov, K.,
Xu, X.,
Mozhayaeva, G.,
Kuo, T.,
Pessah, I.,
Mignery, G.,
Birnbaumer, L.,
and Muallem, S.
(1998)
Nature
396,
478-482
25.
Ma, H.-T.,
Patterson, R. L.,
van Rossum, D. B.,
Birnbaumer, L.,
Mikoshiba, K.,
and Gill, D. L.
(2000)
Science
287,
1647-1651
26.
Bastianutto, C.,
Clementi, E.,
Docazzi, F.,
Podini, P.,
De Georgi, F.,
Rizzutto, R.,
Meldolesi, J.,
and Pozzan, T.
(1995)
J. Cell Biol.
130,
847-855
27.
Mery, L.,
Mesaeli, N.,
Michalak, M.,
Opas, M.,
Lew, D.,
and Krause, K.-H.
(1996)
J. Biol. Chem.
271,
9332-9339
28.
Fasolato, C.,
Pizzo, P.,
and Pozzan, T.
(1998)
Mol. Biol. Cell
9,
1513-1522
29.
Denning, G. M.,
Leidal, K. G.,
Holst, V. A.,
Iyer, S. S.,
Pearson, D. W.,
Clark, J. R.,
Nauseef, W. M.,
and Clark, R. A.
(1997)
Blood
90,
372-381
30.
Swick, A. G.,
Janicor, M.,
Cheneval-Kastelic, T.,
McLenithan, J. C.,
and Lane, M. D.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
1812-1816
31.
DeLisle, S.,
Krause, K.-H.,
Denning, G.,
Potter, B. V. L.,
and Welsh, M. J.
(1990)
J. Biol. Chem.
265,
11726-11730
32.
DeLisle, S.,
Blondel, O.,
Longo, F. J.,
Schnabel, W. E.,
Bell, G. I.,
and Welsh, M. J.
(1996)
Am. J. Physiol.
270,
C1255-C1261
33.
Parys, J. B.,
Sernett, S. W.,
DeLisle, S.,
Snyder, P. M.,
Welsh, M. J.,
and Campbell, K. P.
(1992)
J. Biol. Chem.
267,
18776-18782
34.
Moreau, M.,
Vilain, J. P.,
and Guerrier, P.
(1980)
Dev. Biol.
78,
201-214
35.
Robinson, K. R.
(1985)
Dev. Biol.
109,
504-508
36.
Han, J. K.,
and Nuccitelli, R.
(1990)
J. Cell Biol.
110,
1103-1110
37.
Parker, I.,
and Miledi, R.
(1987)
Proc. R. Soc. Lond. Ser. B Biol. Sci.
231,
27-36
38.
Takahashi, T.,
Neher, E.,
and Sakmann, B.
(1987)
Proc. Natl. Acad. Sci. U. S. A.
84,
5063-5067
39.
Miledi, R.,
and Parker, I.
(1989)
J. Physiol. (Lond.)
415,
189-210
40.
Brooker, G.,
Seki, T.,
Croll, D.,
and Wahlestedt, C.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
2813-2817
41.
Picard, A.,
Cavadore, J.-C.,
Lory, P.,
Bernengo, J.-C.,
Ojeda, C.,
and Dorée, M.
(1990)
Science
247,
327-329
42.
Petersen, C. C. H.,
and Berridge, M. J.
(1994)
J. Biol. Chem.
269,
32246-32253
43.
Yao, Y.,
and Tsien, R. Y.
(1997)
J. Gen. Physiol.
109,
703-715
44.
Miyawaki, A.,
Liopis, J.,
Helm, R.,
McCaffery, J. M.,
Aeams, J. A.,
Ikura, M.,
and Tsien, R. Y.
(1997)
Nature
388,
882-887
45.
Lipp, P.,
and Niggli, E.
(1993)
Cell Calcium
14,
359-372
46.
DeLisle, S.,
and Welsh, M. J.
(1992)
J. Biol. Chem.
267,
7963-7966
47.
Parys, J. B.,
McPherson, S. M.,
Mathews, L.,
Campbell, K. P.,
and Longo, F. J.
(1994)
Dev. Biol.
161,
466-476
48.
Parker, I.,
and Miledi, F. R. S.
(1986)
Proc. R. Soc. Lond. Ser. B Biol. Sci.
228,
307-315
49.
Gillo, B.,
Lass, Y.,
Nadler, E.,
and Oron, Y.
(1987)
J. Physiol. (Lond.)
392,
349-361
50.
Snyder, P. M.,
Krause, K.-H.,
and Welsh, M. J.
(1988)
J. Biol. Chem.
263,
11048-11051
51.
Hartzell, H. C.
(1996)
J. Gen. Physiol.
108,
157-175
52.
DeLisle, S.,
Marksberry, E. W.,
Bonnett, C.,
Jenkins, D. J.,
Potter, B. V. L.,
Takahashi, M.,
and Tanzawa, K.
(1997)
J. Biol. Chem.
272,
9956-9961
53.
Camacho, P.,
and Lechleiter, J. D.
(1995)
Cell
82,
765-771
54.
Lechleiter, J. D.,
and Clapham, D. E.
(1992)
Cell
69,
283-294
55.
John, L. M.,
Lechleiter, J. D.,
and Camacho, P.
(1998)
J. Cell Biol.
142,
963-973
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
Y. Hayashida, Y. Urata, E. Muroi, T. Kono, Y. Miyata, K. Nomata, H. Kanetake, T. Kondo, and Y. Ihara Calreticulin Represses E-cadherin Gene Expression in Madin-Darby Canine Kidney Cells via Slug J. Biol. Chem., October 27, 2006; 281(43): 32469 - 32484. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ihara, Y. Urata, S. Goto, and T. Kondo Role of calreticulin in the sensitivity of myocardiac H9c2 cells to oxidative stress caused by hydrogen peroxide Am J Physiol Cell Physiol, January 1, 2006; 290(1): C208 - C221. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Wilczynska, K. Happle, A. Muller-Taubenberger, C. Schlatterer, D. Malchow, and P. R. Fisher Release of Ca2+ from the Endoplasmic Reticulum Contributes to Ca2+ Signaling in Dictyostelium discoideum Eukaryot. Cell, September 1, 2005; 4(9): 1513 - 1525. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mery, F. Aimond, C. Menard, K. Mikoshiba, M. Michalak, and M. Puceat Initiation of Embryonic Cardiac Pacemaker Activity by Inositol 1,4,5-Trisphosphate-dependent Calcium Signaling Mol. Biol. Cell, May 1, 2005; 16(5): 2414 - 2423. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Treves, C. Franzini-Armstrong, L. Moccagatta, C. Arnoult, C. Grasso, A. Schrum, S. Ducreux, M. X. Zhu, K. Mikoshiba, T. Girard, et al. Junctate is a key element in calcium entry induced by activation of InsP3 receptors and/or calcium store depletion J. Cell Biol., August 16, 2004; 166(4): 537 - 548. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Arnaudeau, M. Frieden, K. Nakamura, C. Castelbou, M. Michalak, and N. Demaurex Calreticulin Differentially Modulates Calcium Uptake and Release in the Endoplasmic Reticulum and Mitochondria J. Biol. Chem., November 22, 2002; 277(48): 46696 - 46705. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Ding, B. Albrecht, R. E. Kelley, N. Muthusamy, S.-J. Kim, R. A. Altschuld, and M. D. Lairmore Human T-Cell Lymphotropic Virus Type 1 p12I Expression Increases Cytoplasmic Calcium To Enhance the Activation of Nuclear Factor of Activated T Cells J. Virol., September 11, 2002; 76(20): 10374 - 10382. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Clark, S.-L. Li, D. W. Pearson, K. G. Leidal, J. R. Clark, G. M. Denning, R. Reddick, K.-H. Krause, and A. J. Valente Regulation of Calreticulin Expression during Induction of Differentiation in Human Myeloid Cells. EVIDENCE FOR REMODELING OF THE ENDOPLASMIC RETICULUM J. Biol. Chem., August 23, 2002; 277(35): 32369 - 32378. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kageyama, Y. Ihara, S. Goto, Y. Urata, G. Toda, K. Yano, and T. Kondo Overexpression of Calreticulin Modulates Protein Kinase B/Akt Signaling to Promote Apoptosis during Cardiac Differentiation of Cardiomyoblast H9c2 Cells J. Biol. Chem., May 24, 2002; 277(22): 19255 - 19264. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Persson, S. E. Wyatt, J. Love, W. F. Thompson, D. Robertson, and W. F. Boss The Ca2+ Status of the Endoplasmic Reticulum Is Altered by Induction of Calreticulin Expression in Transgenic Plants Plant Physiology, July 1, 2001; 126(3): 1092 - 1104. [Abstract] [Full Text] [PDF] |
||||
![]() |
|